BCL2 and cancer: Resistance to apoptosis in cancer cells severely impairs the efficacy of chemotherapy, which is mainly mediated by Bcl-2 protein family, inhibitors of apoptosis proteins (IAPs) and cellular FADD-like IL-1β-converting enzyme-inhibitory protein (c-FLIP) 80.